2019, Number S1
<< Back Next >>
Rev Mex Anest 2019; 42 (S1)
Implications of neuromuscular blockade in the cancer patient. Current management strategy
Tomás-Mateos MJ
Language: Spanish
References: 8
Page: 201-202
PDF size: 86.30 Kb.
Text Extraction
No abstract.
REFERENCES
Jiang A, Zhao H, Liu X, Yu M, Chen J, Jiang WG. Comparison of different muscle-relaxant anesthetics on growth, migration and invasion of gastric cancer cells. Anticancer Research. 2017;37:4371-4378.
Yue H, Han J, Liu L, Wang K, Li J. Effect of rocuronium on the bispectral index under anesthesia and tracheal intubation. Experimental and Therapeutic Medicine. 2016;12:3785-3789.
Zanjani AP, Maghsoudloo M, Makarem J, et al. Chemotherapy alters cisatracurium induced neuromuscular blockade characteristics: a prospective cohort study. Journal of Clinical Anesthesia. 2017;36:84-87.
Holt NF. Chapter 28. Cancer. Stoelting’s Anesthesia and Co-Existing Disease. 585-610.
Yabasin IB, Lu Z, Jia-Chuan Y, Wen O. Cisatracurium-induced proliferation impairment and death of colorectal cancer cells, HCT116 is mediated by p53 dependent intrinsic apoptotic pathway in vitro. Biomedicine & Pharmacotherapy. 2017;91:320-329.
Jiang A, Zhao H, Jiang WG. Possible effect of muscle-relaxant anaesthetics on invasion, adhesion and migration of breast cancer cells. Anticancer Research. 2016;36:1259-1266.
Kajiura A, Nagata O, Sanui M. The Pringle maneuver reduces the infusion rate of rocuronium required to maintain surgical muscle relaxation during hepatectomy. Journal of Anesthesia. 2018;32:409-413.
Cascella M. Preoperative cardiac evaluation and anesthetic considerations for cancer patients who underwent chemotherapy. Trends in Anaesthesia and Critical Care. 2017;14:9-18.
Full text